Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy with manifestations of hemolytic anemia, thrombocytopenia, and renal impairment. Genetic studies have shown that mutations in complement regulatory proteins predispose to non–Shiga toxin–associated HUS (non-Stx–HUS). We undertook geneti...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Caprioli, Jessica, Noris, Marina, Brioschi, Simona, Pianetti, Gaia, Castelletti, Federica, Bettinaglio, Paola, Mele, Caterina, Bresin, Elena, Cassis, Linda, Gamba, Sara, Porrati, Francesca, Bucchioni, Sara, Monteferrante, Giuseppe, Fang, Celia J., Liszewski, M. K., Kavanagh, David, Atkinson, John P., Remuzzi, Giuseppe
Format: Artigo
Idioma:Inglês
Publicat: The American Society of Hematology 2006
Matèries:
Hemostasis, Thrombosis, and Vascular Biology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895874/
https://ncbi.nlm.nih.gov/pubmed/16621965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2005-10-007252
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars